Search

Search Results for "TENAYA/LUCERNE"

ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?

ASRS 2021: ARCHWAY and TENAYA/LUCERNE

The Art of Drug Choice: International Panel in Wet AMD: Safety Data

Faricimab in Phase 2 and 3

Real-world Switch Case: Wet AMD Patient Who Relies on Family for Transportation thumbnail

Real-world Switch Case: Wet AMD Patient Who Relies on Family for Transportation

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?

Arshad Khanani, MD, MA; and David Lally, MD

ASRS 2021 Coverage: ARCHWAY and TENAYA/LUCERNE

Chirag Jhaveri, MD; and Karl Csaky, MD

ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE

Philip Storey, MD; and Prof. Sobha Sivaprasad

The Art of Drug Choice: International Panel in Wet AMD: Safety Data

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

Faricimab in Phase 2 and 3

Carl Danzig, MD

New Retina Radio ARVO Coverage: Faricimab in Wet AMD: Real-world and Phase 3 Data

Durga Borkar, MD, MMCi and Varun Chaudhary, MD

View More